期刊文献+

神经炎症与阿尔茨海默病 被引量:13

原文传递
导出
摘要 阿尔茨海默病(Alzheimer's disease,AD)是一种病因未明的中枢神经系统变性疾病,是老年期痴呆最常见的原因。临床上以进行性认知功能减退为主要表现,其主要的病理特征为老年斑、神经原纤维缠结、海马和大脑皮质广泛神经元丢失及突触丧失。
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2012年第7期664-665,共2页 Chinese Journal of Behavioral Medicine and Brain Science
基金 国家自然科学基金项目(30971016)
  • 相关文献

参考文献28

  • 1Rogers J, Luber-Narod J, Styren SD,et al. Expression of immune sys- tem-associated antigens by ceils of the human central nervous system : relationship to the pathology of Alzheimers disease. Neurobiol Aging, 1988,9:339-349.
  • 2in tVeld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflam- matory drugs and the risk of Alzheimer "s disease. N Engl J Med, 2001,345 : 1515-1521.
  • 3Akiyama H, Bragger S, Barnum S, et al. Inflammation and alzheimer's. Neurobiol Aging, 2000,21 : 383 -421.
  • 4Luein KM ,Wyss-Coray T. Immune activation in brain aging and neu- rodegeneration : too much or too little? Neuron,2009,64 : 110-122.
  • 5Falsig J,van Beek J,Hermmm C,et al. Molecular basis for detection of in- vading pathogens in the brain. J Neurosci Res,2008,86:1434-1447.
  • 6Salminen A, Ojala J, Kauppinen A, et al. Inflammation in Alzheimers disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol,2009 ,87 :181-194.
  • 7Martinon F, Mayor A,Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol,2009 ,27 :229-265.
  • 8Maezawa I,Zimin PI, Wulff H, et al Amyloid-beta protein oligomer at low nanomolar concentrations activales microglia and induces microgli- al neurotoxicity. J Biol Chem,2011,286 :3693-3706.
  • 9Daly JT, Kotwal GJ. Pro-inflammatcry complement activation by the A beta peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein. Neurobiol Aging, 1998,19:6194527.
  • 10Veerhuis R. Histological and direct evidence for the role of comple- ment in the neuroinflammation of AD. Curt Alzheimer Res,2011,8: 34-58.

二级参考文献14

  • 1Gibson CL, Bath PM, Murphy SP. G-CSF promotes functional recovery. following transient focal cerebral ischemia in mice. Cereb Blood Flow Metab ,2005,25:431-439.
  • 2Schneider A, Kruger C,Steigleder T. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. Clin Invest,2005,115:2083-2098.
  • 3Shyu WC, Lin SZ,Yang HI, et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation ,2004,110 : 1847-1854.
  • 4Lambrechts D,Storkebaum E, Morimoto M,et al. VEGF is a modifier of amyotrophie lateral sclerosis in mice and humans and protects moto- neurons against isehemie death. Nat Genet,2003,34:357-358.
  • 5Smale G, Nichols NR, Brady DR, et al. Evidence for apoptotic cell death in Alzheimers disease. Exp Neurol, 1995,133:225-230.
  • 6Grutter MG. Caspases:key players in programmed cell death. Curt" Opin Struct Bio1,2000 ,10 :649-655.
  • 7Shimohama S, Tanino H, Fujimoto S. Changes in caspase expression in Alzheimers disease:comparison with development and aging. Bio- chem Biophys Res Commun, 1999,256:38 1-384.
  • 8Caroline S,Birgit B,lqoIaan C,et al. In vivo characterization ot endo- thelial cell activation in a transgenie mouse model of Alzheimer's dis- ease. Angiogenesis ,2006,9 : 59-65.
  • 9McGinnis KM, Wang KK,Gnegy ME. Alteration of extracellular calci- um elicits selective modes of cell death and protease activation in SHSY5Y human neuroblastoma cells. Neurochem, 1999,72 : 1853- 1863.
  • 10张作记.行为医学量表手册[J].中国行为医学科学,2001,:118-119.

共引文献7

同被引文献105

引证文献13

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部